Literature DB >> 24577939

Detection of monoclonal IGH rearrangements in circulating cells from healthy first-degree relatives of patients with multiple myeloma.

Herbert García-Castillo1, Evelia Leal-Ugarte, Pablo César Ortiz Lazareno, Esperanza Barrera-Chairez, Víctor Hugo Rosales-García, Patricio Barros-Núñez.   

Abstract

Multiple myeloma (MM) is characterized by abnormal proliferation of clonal plasma cells or monoclonal plasmacytosis, resulting in accumulation of clonal immunoglobulins. Monoclonal gammopathy of unknown significance (MGUS) is considered a premorbid stage for developing MM. Studies have shown an increased risk of MGUS in first-degree relatives of patients with MM. Detection of immunoglobulin heavy chain gene (IGH) rearrangement provides a useful tool for assessing clonality. The aim of this study was to determine clonality in peripheral blood samples from 61 healthy first-degree relatives of MM probands by sorting circulating lymphocytes and detection of the IGH rearrangements in these cells. We detected 16 out of 61 (26.2%) relatives with monoclonal complete and incomplete IGH rearrangements; only three of them showed elevated monoclonal immunoglobulin in the serum protein electrophoresis. We conclude that this strategy is able to identify efficiently clonality in peripheral blood samples from first-degree relatives of patients with MM, who have a non-negligible risk of developing MGUS or other plasma cell dyscrasias.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24577939     DOI: 10.1007/s12032-014-0900-0

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  36 in total

1.  Comparison of capillary electrophoresis and polyacrylamide gel electrophoresis for the evaluation of T and B cell clonality by polymerase chain reaction.

Authors:  N T Beaubier; A P Hart; C Bartolo; C L Willman; D S Viswanatha
Journal:  Diagn Mol Pathol       Date:  2000-09

2.  Validation of immunoglobulin gene rearrangement detection by PCR using commercially available BIOMED-2 primers.

Authors:  R F McClure; P Kaur; E Pagel; P D Ouillette; C E Holtegaard; C L Treptow; P J Kurtin
Journal:  Leukemia       Date:  2006-01       Impact factor: 11.528

3.  Minimal disease detection and confirmation in hematologic malignancies: combining cell sorting with clonality profiling.

Authors:  Barbara K Zehentner; Wayne Fritschle; Tess Stelzer; Keely M Ghirardelli; Kimberly Hunter; Collette Wentzel; Richard Bennington; Christian L Hansen; David Myerson; Michael Kalnoski; Denise A Wells; Michael R Loken
Journal:  Clin Chem       Date:  2006-01-12       Impact factor: 8.327

4.  The use of CD138 positively selected marrow samples increases the applicability of minimal residual disease assessment by PCR in patients with multiple myeloma.

Authors:  Noemí Puig; María E Sarasquete; Miguel Alcoceba; Ana Balanzategui; María C Chillón; Elena Sebastián; Luis A Marín; Marcos González Díaz; Jesús F San Miguel; Ramón García Sanz
Journal:  Ann Hematol       Date:  2012-09-07       Impact factor: 3.673

5.  Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance.

Authors:  Celine M Vachon; Robert A Kyle; Terry M Therneau; Barbara J Foreman; Dirk R Larson; Colin L Colby; Tara K Phelps; Angela Dispenzieri; Shaji K Kumar; Jerry A Katzmann; S Vincent Rajkumar
Journal:  Blood       Date:  2009-01-29       Impact factor: 22.113

6.  Inherited predisposition to CLL is detectable as subclinical monoclonal B-lymphocyte expansion.

Authors:  Andy C Rawstron; Martin R Yuille; Julie Fuller; Matthew Cullen; Ben Kennedy; Stephen J Richards; Andrew S Jack; Estella Matutes; Daniel Catovsky; Peter Hillmen; Richard S Houlston
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

7.  Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.

Authors:  Patricia Martín-Jiménez; Ramón García-Sanz; Ana Balanzategui; Miguel Alcoceba; Enrique Ocio; Maria Luz Sanchez; Marcos González; Jesus San Miguel
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

8.  Analysis of B-lymphoid malignancies using allele-specific polymerase chain reaction: a technique for sequential quantitation of residual disease.

Authors:  D Billadeau; M Blackstadt; P Greipp; R A Kyle; M M Oken; N Kay; B Van Ness
Journal:  Blood       Date:  1991-12-01       Impact factor: 22.113

9.  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.

Authors: 
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

Review 10.  Plasma cell myeloma.

Authors:  Pei Lin
Journal:  Hematol Oncol Clin North Am       Date:  2009-08       Impact factor: 3.722

View more
  1 in total

1.  Monitoring immunoglobulin heavy chain and T-cell receptor gene rearrangement in cfDNA as minimal residual disease detection for patients with acute myeloid leukemia.

Authors:  Ling Zhong; Jiao Chen; Xiaobing Huang; Yanxing Li; Tao Jiang
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.